The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Structural and genetic basis for development of broadly neutralizing influenza antibodies
Open accessAbstract
Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglutinin (HA) protein have invigorated efforts to develop universal influenza vaccines. Specifically, antibodies to the highly conserved stem region of HA neutralize diverse viral subtypes. These antibodies largely derive from a specific antibody gene, heavy-chain variable region IGHV1-69, after limited affinity maturation from their germline ancestors, but how HA stimulates naive B cells to mature and induce protective immunity is unknown. To address this question, we analysed the structural and genetic basis for their engagement and maturation into broadly neutralizing antibodies. Here we show that the germline-encoded precursors of these antibodies act as functional B-cell antigen receptors (BCRs) that initiate subsequent affinity maturation. Neither the germline precursor of a prototypic antibody, CR6261 (ref. 3), nor those of two other natural human IGHV1-69 antibodies, bound HA as soluble immunoglobulin-G (IgG). However, all three IGHV1-69 precursors engaged HA when the antibody was expressed as cell surface IgM. HA triggered BCR-associated tyrosine kinase signalling by germline transmembrane IgM. Recognition and virus neutralization was dependent solely on the heavy chain, and affinity maturation of CR6261 required only seven amino acids in the complementarity-determining region (CDR) H1 and framework region 3 (FR3) to restore full activity. These findings provide insight into the initial events that lead to the generation of broadly neutralizing antibodies to influenza, informing the rational design of vaccines to elicit such antibodies and providing a model relevant to other infectious diseases, including human immunodeficiency virus/AIDS. The data further suggest that selected immunoglobulin genes recognize specific protein structural ‘patterns’ that provide a substrate for further affinity maturation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sequences of proteins of immunological interest
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90805-4 · Cited by 3,363
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Self-citationAntibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
Wrammert, J., Koutsonanos, D., Li, G.-M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777
Standard conformations for the canonical structures of immunoglobulins 1 1Edited by I. A. Wilson
Al-Lazikani, B., Lesk, A. M., & Chothia, C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1354 · Cited by 706
TCR–peptide–MHC interactions in situ show accelerated kinetics and increased affinity
Huppa, J. B., Axmann, M., Mörtelmaier, M. A., Lillemeier, B. F., Newell, E. W., Brameshuber, M., Klein, L. O., Schütz, G. J., & Davis, M. M. (2010) · Nature · doi:10.1038/nature08746 · Cited by 504
Corti, D., Suguitan, A. L., Pinna, D., Silacci, C., Fernandez-Rodriguez, B. M., Vanzetta, F., Santos, C., Luke, C. J., Torres-Velez, F. J., Temperton, N. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41902 · Cited by 437
Klein, G., Giovanella, B., Westman, A., Stehlin, J. S., & Mumford, D. (1975) · Intervirology · doi:10.1159/000149930 · Cited by 426
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Wei, C.-J., Boyington, J. C., McTamney, P. M., Kong, W.-P., Pearce, M. B., Xu, L., Andersen, H., Rao, S., Tumpey, T. M., Yang, Z.-Y., et al. (2010) · Science · doi:10.1126/science.1192517 · Cited by 337
Self-citationHuang, C.-C., Venturi, M., Majeed, S., Moore, M. J., Phogat, S., Zhang, M.-Y., Dimitrov, D. S., Hendrickson, W. A., Robinson, J., Sodroski, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308527100 · Cited by 275
Transmembrane signaling: the joy of aggregation
Metzger, H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.5.1477 · Cited by 273
Xiao, X., Chen, W., Feng, Y., Zhu, Z., Prabakaran, P., Wang, Y., Zhang, M.-Y., Longo, N. S., & Dimitrov, D. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.029 · Cited by 260
Immunization by Avian H5 Influenza Hemagglutinin Mutants with Altered Receptor Binding Specificity
Yang, Z.-Y., Wei, C.-J., Kong, W.-P., Wu, L., Xu, L., Smith, D. F., & Nabel, G. J. (2007) · Science · doi:10.1126/science.1135165 · Cited by 253
Self-citationPrabakaran, P., Gan, J., Feng, Y., Zhu, Z., Choudhry, V., Xiao, X., Ji, X., & Dimitrov, D. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600697200 · Cited by 238
Increased TCR Avidity after T Cell Activation A Mechanism for Sensing Low-Density Antigen
Fahmy, T. (2001) · Immunity · doi:10.1016/s1074-7613(09)00099-5 · Cited by 218
Chan, C. H., Hadlock, K. G., Foung, S. K. H., & Levy, S. (2001) · Blood · doi:10.1182/blood.v97.4.1023 · Cited by 191
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
Ledgerwood, J. E., Wei, C.-J., Hu, Z., Gordon, I. J., Enama, M. E., Hendel, C. S., McTamney, P. M., Pearce, M. B., Yassine, H. M., Boyington, J. C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70240-7 · Cited by 188
Self-citationEvidence for a preformed transducer complex organized by the B cell antigen receptor.
Wienands, J., Larbolette, O., & Reth, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7865 · Cited by 186
Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine
Nabel, G. J., & Fauci, A. S. (2010) · Nature Medicine · doi:10.1038/nm1210-1389 · Cited by 152
Self-citationWei, C., Xu, L., Kong, W., Shi, W., Canis, K., Stevens, J., Yang, Z., Dell, A., Haslam, S. M., Wilson, I. A., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00187-08 · Cited by 147
Self-citationSouto‐Carneiro, M., Longo, N. S., Russ, D. E., Sun, H., & Lipsky, P. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6790 · Cited by 145
Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibody
Luftig, M. A., Mattu, M., Giovine, P. D., Geleziunas, R., Hrin, R. C., Barbato, G., Bianchi, E., Miller, M. D., Pessi, A., & Carfı́, A. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1127 · Cited by 129
Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies
Sui, J., Sheehan, J., Hwang, W. C., Bankston, L. A., Burchett, S. K., Huang, C.-Y., Liddington, R., Beigel, J. H., & Marasco, W. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir121 · Cited by 129
Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination
Kong, W., Hood, C. L., Yang, Z., Wei, C., Xu, L., García‐Sastre, A., Tumpey, T. M., & Nabel, G. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607564103 · Cited by 81
Self-citationHeizmann, B., Reth, M. G., & Infantino, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009048107 · Cited by 58
Gustchina, E., Li, M., Louis, J. M., Anderson, D. E., Lloyd, J., Frisch, C., Bewley, C. A., Gustchina, A., Wlodawer, A., & Clore, G. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001182 · Cited by 48
It's All About Change: The Antigen-driven Initiation of B-Cell Receptor SignalingPreprint
Liu, W., Sohn, H. W., Tolar, P., & Pierce, S. K. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002295 · Cited by 48
Müller, R., Wienands, J., & Reth, M. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8451 · Cited by 40
Cited by
Germinal Center B Cell Dynamics
Mesin, L., Ersching, J., & Victora, G. D. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.001 · Cited by 994
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Self-citationVictora, G. D., & Nussenzweig, M. C. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-120419-022408 · Cited by 824
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Yassine, H. M., Boyington, J. C., McTamney, P. M., Wei, C.-J., Kanekiyo, M., Kong, W.-P., Gallagher, J. R., Wang, L., Zhang, Y., Joyce, M. G., et al. (2015) · Nature Medicine · doi:10.1038/nm.3927 · Cited by 699
Self-citationBroadly Neutralizing Antiviral Antibodies
Corti, D., & Lanzavecchia, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095916 · Cited by 475
Metadata
- Authors
- Lingwood, D., McTamney, P. M., Yassine, H. M., Whittle, J. R. R., Guo, X., Boyington, J. C., Wei, C.-J., & Nabel, G. J.
- Venue
- Nature
- Published
- 2012-08-29
- Volume
- 489
- Issue
- 7417
- Pages
- 566-570
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2087293737
- Cited by
- 268
- References
- 29
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.